fda compounded semaglutide enforcement news Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots

September 2, 2025: U.S. compounding restrictions have stemmed a flood of compounded semaglutide and tirzepatide – Partnership for Safe Medicines

22.58

★★★★☆4.8 (126)

Compounded "semaglutide" is not FDA-approved

27.04

★★★★★4.9 (98)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

25.68

★★★★★5.0 (157)

Drug compounders sue FDA over declaration ending Wegovy shortage

21.20

★★★★★4.7 (84)

The push to make weight-loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and

20.51

★★★★★4.9 (203)

In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking

28.71

★★★★★5.0 (176)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

24.25

★★★★★4.8 (132)